SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED

Highlights Shandong Xinhua Pharmaceutical Company Limited

Equities

719 CNE100000411

Market Closed - Hong Kong S.E. Other stock markets 04:09:00 2024-05-03 am EDT			5-day change	1st Jan Change
5.44 ^HKD	-1.45%		-0.18%	-5.88%

Apr. 25	Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 11	Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation	Apr. 11	MT
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Supplementary Drug Application	Apr. 08	CI
Shandong Xinhua Pharmaceutical Posts Higher 2023 Profit	Mar. 29	MT
Shandong Xinhua Pharmaceutical Company Limited Proposes Final Dividend for the Year Ended 31 December 2023	Mar. 28	CI
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Xinhua Pharma's Ibuprofen Gets Registration Approval in China	Mar. 13	MT
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Application for Marketing of Active Pharmaceutical Ingredient	Feb. 28	CI
Shandong Xinhua Pharmaceutical Company Limited Announces on Memantine Hydrochloride Tablets Obtaining the Drug Registration Certificate	Jan. 19	CI
Shandong Xinhua Pharmaceutical Gets Certificate for Registration of Levamlodiping Besylate Tablets	Dec. 13	MT
Shandong Xinhua Pharmaceutical Company Limited Receives Drug Registration Certificate of levamlodiping besylate tablets (2.5mg)	Dec. 13	CI
Xinhua Pharmaceutical's Nine-Month Profit Jumps 34%	23-10-30	MT
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shandong Xinhua Pharmaceutical Company Limited Announces Approval of Marketing Application for Chemical Raw Material Drugs for Drugsof Febuxostat	23-10-10	CI
Xinhua Pharmaceutical Unit's Clarithromycin Granules Passes Regulatory Evaluation	23-09-20	MT
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Shandong Xinhua Pharmaceutical Company Limited Receives the Drug Registration Certificate of Alogliptin Benzoate Tablets Approved and Issued by the National Medical Products Administration	23-08-11	CI
Shandong Xinhua Pharmaceutical Company Limited Announces Final Dividend on A Shares for the Year 2022, Payable on July 26, 2023	23-07-19	CI
Shandong Xinhua Pharmaceutical Company Limited Announces Rabeprazole Sodium Enteric-coated Tablets Passing the GenericsConsistency Evaluation	23-07-14	CI
Xinhua Pharma's Heart Drug Passes Regulatory Evaluation in China	23-07-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Shandong Xinhua Pharmaceutical Company Limited

Equities

719

CNE100000411

Highlights

Filters